| Stage | VIR | % of rev | AMGN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $239M | 100.00% | $10.4B | 100.00% | AMGN ×43.38 |
| Gross profit | $239M | 100.00% | $7.6B | 73.10% | VIR +26.9pp |
| Operating income | $73M | 30.75% | $3.7B | 35.79% | AMGN +5.0pp |
| Pre-tax income | $80M | 33.59% | $4.7B | 45.21% | AMGN +11.6pp |
| Net income | $80M | 33.51% | $3.9B | 37.28% | AMGN +3.8pp |
| Stage | VIR | AMGN | Gap · A − B |
|---|---|---|---|
| Revenue | $239M100.00% | $10.4B100.00% | AMGN ×43.38 |
| Gross profit | 100.00%$239M | 73.10%$7.6B | VIR +26.9pp |
| Operating income | 30.75%$73M | 35.79%$3.7B | AMGN +5.0pp |
| Pre-tax income | 33.59%$80M | 45.21%$4.7B | AMGN +11.6pp |
| Net income |
| 33.51%$80M |
| 37.28%$3.9B |
| AMGN +3.8pp |
No shared counterparties.